Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Protillion Biosciences
company
About
Protillion Biosciences specializes in the design and development of protein-based drugs.
- Burlingame,California,United States
- 1 - 10
- https://www.protillion.com
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $18M
- Industries
- Biopharma,Biotechnology,Genetics
- Founded date
- Jan 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Also Known As
- Protillion
Protillion Biosciences is a biotech company commercializing disruptive technology for therapeutic antibody and drug discovery and accelerating biologic research and development productivity.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$18M
Protillion Biosciences has raised a total of
$18M
in funding over 2 rounds. Their latest funding was raised on
Dec 19, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 19, 2022 | Series A | $18M | 2 |
ARCH Venture Partners
Illumina Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Protillion Biosciences is funded by 2 investors.
ARCH Venture Partners
and Illumina Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
ARCH Venture Partners
|
Yes | Series A |
|
Illumina Ventures
|
Yes | Series A |
Employee Profiles
Number of Employee Profiles
3
Protillion Biosciences has 3 current employee profiles, including
Board member David R. Walt
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
